ROCKET PHARMACEUTICALS, INC.·4

Sep 15, 4:07 PM ET

Garcia-Parada Carlos 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Sep 15, 2021

Insider Transaction Report

Form 4
Period: 2021-09-13
Garcia-Parada Carlos
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-13+40,00040,000 total
    Exercise: $35.60Exp: 2031-09-13Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on September 13, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4